Table 3.
Estimated effects of intervention compared to control on the change from baseline of continuous outcomes.
| Secondary continuous outcome | Control, mean (SD) | Intervention, mean (SD) | Primary modela | ||
|
|
Mean differences (95% CI) | P value | |||
| The change from baseline of: | |||||
|
|
HbA1cb level, % | x.xx (x.xx) | x.xx (x.xx) | x.xx (x.xx-x.xx) | .xx |
|
|
FBGc level, mmol/L | x.xx (x.xx) | x.xx (x.xx) | x.xx (x.xx-x.xx) | .xx |
|
|
Systolic blood pressure, mmHg | x.xx (x.xx) | x.xx (x.xx) | x.xx (x.xx-x.xx) | .xx |
|
|
Diastolic blood pressure, mmHg | x.xx (x.xx) | x.xx (x.xx) | x.xx (x.xx-x.xx) | .xx |
|
|
LDL-Cd level, mmol/L | x.xx (x.xx) | x.xx (x.xx) | x.xx (x.xx-x.xx) | .xx |
aPrimary model: linear regression with generalized estimating equation and with adjustment of baseline value of the analyzed outcome and clustering.
bHbA1c: glycated hemoglobin.
cFBG: fasting blood glucose.
dLDL-C: low-density lipoprotein cholesterol.